CHIAPPINI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 862
AS - Asia 604
EU - Europa 484
SA - Sud America 194
AF - Africa 21
OC - Oceania 2
Totale 2.167
Nazione #
US - Stati Uniti d'America 816
SG - Singapore 299
BR - Brasile 164
CN - Cina 146
DE - Germania 119
IT - Italia 103
IE - Irlanda 60
VN - Vietnam 57
SE - Svezia 40
FI - Finlandia 31
CA - Canada 23
MX - Messico 23
IN - India 22
RU - Federazione Russa 22
GB - Regno Unito 20
AT - Austria 16
FR - Francia 15
AR - Argentina 13
ES - Italia 13
HK - Hong Kong 13
KR - Corea 12
NL - Olanda 12
PL - Polonia 12
TR - Turchia 9
ZA - Sudafrica 9
BD - Bangladesh 7
JP - Giappone 7
LT - Lituania 7
EC - Ecuador 6
IQ - Iraq 6
EG - Egitto 4
HU - Ungheria 4
UZ - Uzbekistan 4
IL - Israele 3
MA - Marocco 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
KE - Kenya 2
TN - Tunisia 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.167
Città #
Singapore 213
Ashburn 140
Munich 85
Dallas 71
Dublin 60
The Dalles 59
Chandler 54
Los Angeles 47
Beijing 45
São Paulo 33
Ho Chi Minh City 25
New York 25
Santa Clara 22
Princeton 19
Hefei 18
Redondo Beach 18
Rome 18
Tongling 18
Buffalo 14
Denver 14
Turku 13
Washington 13
Hong Kong 12
Warsaw 11
Chennai 10
Düsseldorf 10
Helsinki 10
Montreal 10
Frankfurt am Main 9
Nuremberg 9
Toronto 9
Altamura 8
Boardman 8
Boston 8
Johannesburg 8
Lappeenranta 8
Vienna 8
Atlanta 7
San Francisco 7
Seoul 7
Tokyo 7
Amsterdam 6
Hanoi 6
Houston 6
Lauterbourg 6
Mexico City 6
Silvi 6
Ankara 5
Chicago 5
Orem 5
Phoenix 5
Stockholm 5
Augusta 4
Brooklyn 4
Campinas 4
Gwangju 4
Mumbai 4
Portsmouth 4
Querétaro 4
Tashkent 4
Baghdad 3
Belo Horizonte 3
Budapest 3
Camerino 3
City of London 3
Council Bluffs 3
Curitiba 3
Da Nang 3
Hải Dương 3
Milan 3
New Delhi 3
Norfolk 3
Poplar 3
Porto Alegre 3
San Benedetto del Tronto 3
San Jose 3
Scandicci 3
Seattle 3
Xiamen 3
Asunción 2
Bari 2
Bismarck 2
Bogotá 2
Bologna 2
Brussels 2
Bắc Giang 2
Cairo 2
Casalbordino 2
Castignano 2
Caxias do Sul 2
Charleston 2
Cleveland 2
Dongguan 2
Elk Grove Village 2
Fes 2
Goiânia 2
Guangzhou 2
Guayaquil 2
Hyderabad 2
Islamabad 2
Totale 1.382
Nome #
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 78
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 76
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 74
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 74
Misuse of Anticholinergic Medications: A Systematic Review 73
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 73
Climate change, biodiversity loss and mental health: a global perspective 71
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 70
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 67
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 66
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 64
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 63
Brexpiprazole as a new approach of treatment in somatization disorder 63
Opioid painkiller dependence in a sample of elderly medical inpatients 63
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 63
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 62
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report 62
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 61
New psychoactive substances and suicidality: A systematic review of the current literature 61
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 61
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 60
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 60
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 59
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 58
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 57
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 55
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 51
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 48
The benzydamine experience: a systematic review of benzydamine abuse 46
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 45
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 43
Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review 41
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 39
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 38
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 38
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 37
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 37
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 32
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 32
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality 26
Emerging strategies and clinical recommendations for the management of novel depression subtypes 25
Totale 2.272
Categoria #
all - tutte 12.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 1 9 0 0 0
2021/202242 0 0 0 1 0 0 0 9 2 11 1 18
2022/2023199 9 25 12 10 19 37 11 17 45 4 2 8
2023/2024250 11 18 34 12 29 52 25 10 11 14 5 29
2024/2025724 60 88 51 16 27 16 32 23 69 91 125 126
2025/20261.047 174 101 174 286 236 76 0 0 0 0 0 0
Totale 2.272